HomeTag

Aprecia Pharmaceuticals - Prometheus IP

by prometheusip  August 17, 2015

The FDA has approved the world’s first 3D printed drug for the treatment of epilepsy. The new drug, Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy. The 3D technology allows Spritam (levetiracetam) to have higher manufacturing precision thus accommodating a higher dose almost upto 1000 mg in each tablet. As...

Hyderabad
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social
Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social

Copyright Prometheus IP. All rights reserved.

Copyright Prometheus IP. All rights reserved.